Monitor for allergic reactions, especially during the first few administrations
GLP-1 medications are considered long-term, chronic-disease therapies for both diabetes and obesity
Full ingredient list Water, Centella Asiatica Extract (12.3%), Glycerin, Cetyl Ethylhexanoate, Cetearyl Alcohol, Glyceryl Stearate, Glutathione (1,000ppm), Niacinamide (1,000ppm), Madecassic Acid, Asiaticoside, Asiatic Acid, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, Hydrolyzed Collagen, Beta-Glucan, Hippophae Rhamnoides Fruit Extract, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Squalane, Sodium Hyaluronate, Dipropylene Glycol, Butylene Glycol, Hydrogenated Lecithin, Cholesterol, Xanthan Gum, Potassium Hydroxide, Disodium EDTA, Caprylic/Capric Triglyceride, Cyclopentasiloxane, Cyclohexasiloxane, Saccharide Hydrolysate, Sorbitan Stearate, Dimethicone, PEG-100 Stearate, Stearic Acid, 1,2-Hexanediol, Chlorphenesin, Carbomer, Caprylyl Glycol
Farxiga is approved for non-diabetic patients with heart failure or chronic kidney disease, but not specifically for weight loss
A 20% reduction in peak concentration is meaningful for concentration-dependent side effects
10.2174/1389203717666151201192247 32 SugiyamaS.Di NardoA
